The virtual liver: state of the art and future perspectives

Archives of Toxicology

Volumn 88, Issue 12, 2014, Pages 2071-2075

  Drasdo, Dirk ^a,b,c   Bode, Johannes ^d   Dahmen, Uta ^e   Dirsch, Olaf ^e   Dooley, Steven ^f   Gebhardt, Rolf ^c   Ghallab, Ahmed ^g,h   Godoy, Patricio ^g   Häussinger, Dieter ⁱ   Hammad, Seddik ^g,h   Hoehme, Stefan ^c   Holzhütter, Hermann Georg ⁱ   Klingmüller, Ursula ^j   Kuepfer, Lars ^k,l   Timmer, Jens ^m   Zerial, Marino ⁿ   Hengstler, Jan G ^g  

^a INRIA   (France)

^b UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^h SOUTH VALLEY UNIVERSITY   (Egypt)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k BAYER AG   (Germany)

^l RWTH AACHEN UNIVERSITY   (Germany)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCAGON; GLUCOSE; INSULIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AMINO ACID METABOLISM; CELL COMMUNICATION; EDITORIAL; ENDOSOME; GLUCOSE HOMEOSTASIS; IMAGE ANALYSIS; LIPIDOMICS; LIVER; LIVER CELL; LIVER FUNCTION; LIVER METABOLISM; MATHEMATICAL MODEL; PROTEOMICS; SYSTEMS BIOLOGY; BIOLOGICAL MODEL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; HUMAN; LIVER DISEASES; METABOLISM; PATHOLOGY; PROCEDURES; TRENDS; ULTRASTRUCTURE;

COMPUTER SIMULATION; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; LIVER; LIVER DISEASES; MODELS, BIOLOGICAL;

EID: 84912527851     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1384-6     Document Type: Editorial

References (42)

1. Blüthgen N, Legewie S, Kielbasa SM et al (2009) A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts. FEBS J 276:1024–1035
2. Bucher J, Riedmaier S, Schnabel A et al (2011) A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes. BMC Syst Biol 5:66
3. Casanovas G, Banerji A, d’Alessio F et al (2014) A multi-scale model of hepcidin promoter regulation reveals factors controlling systemic iron homeostasis. PLoS Comput Biol 10:e1003421
4. Diaz Ochoa JG, Bucher J, Péry AR et al (2013) A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk. Front Pharmacol 22:204
5. Ding BS, Nolan DJ, Butler JM et al (2010) Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468:310–315
6. Ding BS, Cao Z, Lis R et al (2014) Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 505:97–102
7. Dooley S, Hamzavi J, Ciuclan L et al (2008) Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135:642–659
8. Drasdo D, Hoehme S, Hengstler JG (2014) How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis. J Hepatol 61:951–956
9. Ehlting C, Ronkina N, Böhmer O et al (2011) Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J Biol Chem 286:24113–24124
10. El Maadidi S, Faletti L, Berg B et al. (2014) A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis. J Immunol 192:1171–1183
11. Geissler A, Haun F, Frank DO et al (2013) Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ 20:1317–1329
12. Gille C, Bölling C, Hoppe A et al (2010) HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol Syst Biol 6:411
13. Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87:1315–1530
14. Hammad S, Hoehme S, Friebel A et al (2014) Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis. Arch Toxicol 88:1161–1183
15. Heise T, Schug M, Storm D et al (2012) In vitro–in vivo correlation of gene expression alterations induced by liver carcinogens. Curr Med Chem 19:1721–1730
16. Hoehme S, Brulport M, Bauer A et al (2010) Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci USA 107:10371–10376
17. 4). Chem Biol Interact 168:74–93
18. Hu J, Srivastava K, Wieland M et al (2014) Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science 343:416–419
19. Huard J, Mueller S, Gilles ED et al (2012) An integrative model links multiple inputs and signaling pathways to the onset of DNA synthesis in hepatocytes. FEBS J 279:3290–3313
20. König M, Holzhütter HG (2012) Kinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy. J Biol Chem 287:36978–36989
21. König M, Bulik S, Holzhütter HG (2012) Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol 8:e1002577
22. Krauss M, Schaller S, Borchers S et al (2012) Integrating cellular metabolism into a multiscale whole-body model. PLoS Comput Biol 8:e1002750
23. Krauss M, Burghaus R, Lippert J et al (2013) Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification. In Silico Pharmacol 1:6
24. Kuepfer L, Kerb R, Henney AM (2014) Clinical translation in the virtual liver network. CPT Pharmacometrics Syst Pharmacol 3:e127
25. Lippert J, Brosch M, von Kampen O et al (2012) A mechanistic, model-based approach to safety assessment in clinical development. CPT Pharmacometrics Syst Pharmacol 1:e13
26. Magdy T, Arlanov R, Winter S et al (2013) ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression. Pharmacogenomics 14:1433–1448
27. Mielke H, Anger LT, Schug M et al (2011) A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testing. Arch Toxicol 85:555–563
28. Mleczko-Sanecka K, Casanovas G, Ragab A et al (2010) SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood 115:2657–2665
29. Pelz S, Stock P, Brückner S, Christ B (2012) A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Exp Cell Res 318:276–287
30. Popper K (1934) Logik der Forschung. 11. Aufl. 2005. ISBN 3-16-148410-X
31. Schleicher J, Guthke R, Dahmen U et al (2014) A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease. Biochim Biophys Acta 1841:62–69
32. Schliess F, Hoehme S, Henkel SG, Ghallab A, Driesch D, Böttger J, Guthke R, Pfaff M, Hengstler JG, Gebhardt R, Häussinger D, Drasdo D, Zellmer S (2014) Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration. Hepatology. doi:10.1002/hep.27136
33. Schug M, Stöber R, Heise T et al (2013) Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes. Arch Toxicol 87:337–345
34. Schwen LO, Krauss M, Niederalt C et al (2014) Spatio-temporal simulation of first pass drug perfusion in the liver. PLoS Comput Biol 10:e1003499
35. Stewart JD, Marchan R, Lesjak MS et al (2012) Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis. Proc Natl Acad Sci USA 109:8155–8160
36. Thiele I, Swainston N, Fleming RM et al (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol 31:419–425
37. Thomas M, Burk O, Klumpp B et al (2013) Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα). Mol Pharmacol 83:709–718
38. Vlaic S, Schmidt-Heck W, Linde J et al (2012) Modeling the transcription factor network of murine hepatocytes using the extended TILAR approach. BMC Syst Biol 29:147
39. Walter D, Schmich K, Vogel S et al (2008) Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes. Hepatology 48:1942–1953
40. Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–141 Review
41. Zeigerer A, Gilleron J, Bogorad RL et al (2012) Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 485:465–470
42. Zellmer S, Schmidt-Heck W, Godoy P et al (2010) Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes. Hepatology 52:2127–2136